Form 8-K - Current report:
SEC Accession No. 0001999371-25-004807
Filing Date
2025-04-25
Accepted
2025-04-25 16:59:30
Documents
13
Period of Report
2025-04-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp_8k-042525.htm   iXBRL 8-K 32649
  Complete submission text file 0001999371-25-004807.txt   206266

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE tnxp-20250425.xsd EX-101.SCH 3023
3 XBRL LABEL FILE tnxp-20250425_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE tnxp-20250425_pre.xml EX-101.PRE 22364
15 EXTRACTED XBRL INSTANCE DOCUMENT tnxp_8k-042525_htm.xml XML 3543
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 25875023
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)